Zions Bancorporation’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-4,067
Closed -$386K 832
2018
Q3
$386K Sell
4,067
-886
-18% -$75.5K 0.09% 107
2018
Q2
$382K Sell
4,953
-8,940
-64% -$671K 0.26% 59
2018
Q1
$960K Buy
13,893
+30
+0.2% +$2.29K 0.21% 45
2017
Q4
$1.03M Buy
13,863
+26
+0.2% +$1.66K 0.18% 56
2017
Q3
$876K Buy
13,837
+615
+5% +$38.2K 0.13% 102
2017
Q2
$844K Buy
13,222
+9,892
+297% +$621K 0.14% 82
2017
Q1
$220K Sell
3,330
-111
-3% -$7.64K 0.04% 114
2016
Q4
$237K Sell
3,441
-838
-20% -$60.1K 0.04% 109
2016
Q3
$300K Buy
4,279
+237
+6% +$17.7K 0.06% 97
2016
Q2
$308K Sell
4,042
-236
-6% -$17.4K 0.05% 96
2016
Q1
$301K Buy
4,278
+3,138
+275% +$226K 0.05% 99
2015
Q4
$77K Buy
1,140
+25
+2% +$2.14K 0.01% 170
2015
Q3
$99K Sell
1,115
-1,171
-51% -$102K 0.02% 141
2015
Q2
$203K Buy
2,286
+1,136
+99% +$99.2K 0.03% 133
2015
Q1
$100K Buy
+1,150
New +$96.5K 0.02% 168

Other funds holding ESRX

Zions Bancorporation's ESRX Position: Q4 2018 in Review

Zions Bancorporation sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 4,067 shares — an estimated $386K sold.

Zions Bancorporation first reported a position in ESRX in Q1 2015 and held it in 15 quarters. The position peaked at $1.03M in Q4 2017. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Zions Bancorporation reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Zions Bancorporation sold 4,067 Express Scripts Holding Company shares in Q4 2018, an estimated $386K.
  • Zions Bancorporation first reported a position in Express Scripts Holding Company in Q1 2015 and held it in 15 quarters.
  • Zions Bancorporation's Express Scripts Holding Company position peaked at $1.03M in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Zions Bancorporation's 13F filing for Q4 2018, filed 13 Feb 2019.